tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market
HOWL
Werewolf Therapeutics
RESEARCH TOOLSreports
Want to see HOWL full AI Analyst Report?

Werewolf Therapeutics (HOWL) Income Statement

793 Followers

Werewolf Therapeutics Income Statement

Last quarter (Q1 2026), Werewolf Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Werewolf Therapeutics's net income was $-13.53M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 1.89M$ 19.94M$ 16.40M$ 0.00
Gross Profit
$ -1.63M$ 71.00K$ 18.18M$ 13.89M$ 0.00
Operating Expenses
$ 59.04M$ 73.67M$ 58.68M$ 69.95M$ 50.09M
Depreciation and Amortization
$ 1.63M$ 1.81M$ 1.76M$ 2.51M$ 216.00K
EBITDA
$ -59.04M$ -64.05M$ -32.47M$ -51.30M$ -49.87M
Operating Income
$ -60.68M$ -73.59M$ -40.50M$ -56.06M$ -50.09M
Other Income/Expenses
$ -145.00K$ 3.08M$ 3.13M$ 2.25M$ 104.00K
Pretax Income
$ -60.82M$ -70.52M$ -37.37M$ -53.81M$ -49.98M
Net Income
$ -60.82M$ -70.52M$ -37.37M$ -53.81M$ -49.98M
Per Share Metrics
Basic EPS
$ -1.32$ -1.63$ -1.05$ -1.86$ -10.94
Diluted EPS
$ -1.33$ -1.63$ -1.05$ -1.86$ -10.94
Weighted Average Shares Outstanding
 46.02M 43.33M 35.65M 28.86M 18.45M
Weighted Average Shares Outstanding (Diluted)
 46.81M 43.86M 35.65M 28.86M 18.45M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History